ACUTE LYMPHOBKASTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOBKASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBKASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBKASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy aims to tackle tough blood cancers
Disease control Not yet recruitingThis trial tests a new treatment called SHB-02-CD19, which uses a patient's own immune cells engineered to attack cancer cells that have a protein called CD19. It is for children and adults with B-cell cancers (like leukemia or lymphoma) that have come back or not responded to at…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Real-World data sought on Ponatinib's impact against rare leukemia
Disease control Not yet recruitingThis study reviews medical records of 103 adults with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) who received ponatinib as their first treatment in regular care. Researchers want to see how many patients achieve a complete molecular response (undetectable leukem…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for leukemia patients who have run out of options
Disease control Not yet recruitingThis early study tests a new drug called STR-P004 in 11 adults with a type of leukemia (ALL) that has come back or not responded to standard treatments. The main goals are to check if the drug is safe, find the right dose, and see if it helps fight the cancer. Participants will r…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Engineered immune cells take on tough blood cancers
Disease control Not yet recruitingThis early-stage trial tests a personalized cell therapy called CD19/22 CAR-T cells in 17 adults with relapsed or refractory acute lymphoblastic leukemia or B-cell lymphoma. Patients receive their own immune cells that have been reprogrammed to target and kill cancer cells. The s…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology • Aim: Disease control
Last updated Jun 26, 2026 14:45 UTC